Your browser doesn't support javascript.
loading
The two pore potassium channel THIK-1 regulates NLRP3 inflammasome activation.
Drinkall, Samuel; Lawrence, Catherine B; Ossola, Bernadino; Russell, Samuel; Bender, Clare; Brice, Nicola B; Dawson, Lee A; Harte, Michael; Brough, David.
Afiliación
  • Drinkall S; Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Lawrence CB; Division of Neuroscience and Experimental Psychology, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Ossola B; Cerevance Ltd, Cambridge, UK.
  • Russell S; Cerevance Ltd, Cambridge, UK.
  • Bender C; Cerevance Ltd, Cambridge, UK.
  • Brice NB; Cerevance Ltd, Cambridge, UK.
  • Dawson LA; Cerevance Ltd, Cambridge, UK.
  • Harte M; Division of Pharmacy & Optometry, School of Health Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
  • Brough D; The Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK.
Glia ; 70(7): 1301-1316, 2022 07.
Article en En | MEDLINE | ID: mdl-35353387
The NLRP3 (NLR family, pyrin domain containing 3) inflammasome is a multi-protein complex responsible for the activation of caspase-1 and the subsequent cleavage and activation of the potent proinflammatory cytokines IL-1ß and IL-18, and pyroptotic cell death. NLRP3 is implicated as a driver of inflammation in a range of disorders including neurodegenerative diseases, type 2 diabetes, and atherosclerosis. A commonly reported mechanism contributing to NLRP3 inflammasome activation is potassium ion (K+ ) efflux across the plasma membrane. Identification of K+ channels involved in NLRP3 activation remains incomplete. Here, we investigated the role of the K+ channel THIK-1 in NLRP3 activation. Both pharmacological inhibitors and cells from THIK-1 knockout (KO) mice were used to assess THIK-1 contribution to macrophage NLRP3 activation in vitro. Pharmacological inhibition of THIK-1 inhibited caspase-1 activation and IL-1ß release from mouse bone-marrow-derived macrophages (BMDMs), mixed glia, and microglia in response to NLRP3 agonists. Similarly, BMDMs and microglia from THIK-1 KO mice had reduced NLRP3-dependent IL-1ß release in response to P2X7 receptor activation with ATP. Overall, these data suggest that THIK-1 is a regulator of NLRP3 inflammasome activation in response to ATP and identify THIK-1 as a potential therapeutic target for inflammatory disease.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders Asunto principal: Canales de Potasio de Dominio Poro en Tándem / Diabetes Mellitus Tipo 2 / Inflamasomas Límite: Animals Idioma: En Revista: Glia Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_endocrine_disorders Asunto principal: Canales de Potasio de Dominio Poro en Tándem / Diabetes Mellitus Tipo 2 / Inflamasomas Límite: Animals Idioma: En Revista: Glia Asunto de la revista: NEUROLOGIA Año: 2022 Tipo del documento: Article
...